Rheumatology International

Journal Title：Rheumatology International

RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology.

RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production.

Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.

RHEUMATOLOGY INTERNATIONAL 是一份反映世界各地在各种风湿性疾病的研究、诊断和治疗方面取得的进展的独立期刊。它旨在为风湿病领域的研究人员和临床医生服务。

RHEUMATOLOGY INTERNATIONAL 将涵盖临床研究以及风湿性疾病管理的所有现代趋势。将特别强调与风湿病相关的公共卫生问题、将风湿病研究应用于临床实践、风湿病流行病学、风湿病诊断测试、风湿病患者报告结果 (PRO) 和风湿病教育证据。对这些主题的贡献将以原始出版物、简短的交流、社论和评论的形式出现。欢迎“致编辑的信”作为讨论的补充。不鼓励提交基础科学研究，包括体外或动物研究，因为我们只会从流行病学或临床角度审查对人类的研究。没有对文献（基于案例的评论）进行适当审查的病例报告将不会发表。将尽一切努力确保出版速度，同时保持高标准的内容和制作。

提交出版的手稿必须包含一项声明，说明所有人体研究都已经过相应的伦理委员会审查，因此已按照 1964 年赫尔辛基宣言的适当版本中规定的伦理标准进行。还应在正文中明确说明所有人员在纳入研究之前均已签署知情同意书。应省略可能透露研究对象身份的细节。

Rheumatology International创刊于1981年，由SPRINGER HEIDELBERG出版商出版，收稿方向涵盖医学 - 风湿病学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度约16.月，影响因子指数1.984，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。